Glpg1837 dose 1    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis2

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 1,592 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02707562
(ClinicalTrials.gov)
February 201622/2/2016Study of GLPG1837 in Subjects With Cystic Fibrosis (G551D Mutation)A Phase IIa, Open-label Study of Multiple Doses of GLPG1837 in Subjects With Cystic Fibrosis and the G551D MutationCystic FibrosisDrug: GLPG1837 dose 1;Drug: GLPG1837 dose 2;Drug: GLPG1837 dose 3Galapagos NVNULLCompleted18 YearsN/ABoth26Phase 2Australia;Czech Republic;Germany;Ireland;United Kingdom
2NCT02690519
(ClinicalTrials.gov)
January 201616/2/2016Study of GLPG1837 in Subjects With Cystic Fibrosis (S1251N Mutation)A Phase IIa, Open-label Study of Two Doses of GLPG1837 in Subjects With Cystic Fibrosis and the S1251N MutationCystic FibrosisDrug: GLPG1837 dose 1;Drug: GLPG1837 dose 2Galapagos NVNULLCompleted18 YearsN/ABoth7Phase 2Belgium;Netherlands